Hemagard HGK1809Recalls & reported problems
Intervascular Sas · Hemagard Knitted Bifurcated Collagen Coated Vascular Graft · Class 2 · Implant
All models of Hemagard (28)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 5
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00384401014393), received between Oct 2, 2015 and May 3, 2019 — classified as 3 injuries, 2 malfunctions.
The most frequently reported specific device problem is “Manufacturing, Packaging or Shipping Problem” (4 reports).
2 other recalls cover devices cleared under the same FDA submission (K964625); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Manufacturing, Packaging or Shipping Problem4
- Improper or Incorrect Procedure or Method1
Patient problems
- Blood Loss5
Recent adverse event reports
The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 3, 2019Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem
AFTER ANASTOMOSIS OF PROXIMAL AND DISTAL ENDS, CLINICIAN REPORTED BLOOD WEEPING THROUGH BODY OF THE GRAFT ONCE THE CLAMPS WERE REMOVED. TWO CASES WERE REPORTED TOGETHER BY SAME CLINICIAN (SEE MANUFACTURER REPORT 1640201-2019-00027 FOR OTHER CASE). SURGEON ALLOWED THE BLOOD TO WEEP THROUGH THEN CLAMP FOR A FEW MINUTES TO ALLOW THE BLOOD TO COAGULATE TO GRAFT WALL THEN PROCEEDED WITH REST OF SURGERY. NO INDICATION OF ACTUAL OR POTENTIAL HARM OF PATIENT.
Patient problems: Blood Loss
MAUDE report 8578403 ↗InjuryJun 8, 2017Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem
DURING AN AORTO-BIFEMORAL PROCEDURE, PERFORMED ON (B)(6) 2017, IT WAS REPORTED THERE WAS A LOT OF BLEEDING DURING THE PROCEDURE . THE BLEEDING WAS STOPPED BY CLAMPING THE GRAFT. THE PATIENT HAD A LOW BLOOD PRESSURE, AND UNEXPECTED BLOOD TRANSFUSION WAS PERFORMED. IT WAS ALSO REPORTED THAT BEFORE THE AORTO-BIFEMORAL IMPLANTATION, A TEMPORARY AXILLOBIFEMORAL SHUNT WAS PERFORMED WITH ANOTHER GRAFT HGK0010-100 WITHOUT BLEEDING. NO CONSEQUENCE FOR THE PATIENT WAS REPORTED.
Patient problems: Blood Loss
MAUDE report 6621259 ↗InjuryMay 23, 2017Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem
DURING A SURGERY PERFORMED ON (B)(6) 2017, THE HOSPITAL REPORTED THAT THERE WAS AN EXCESSIVE LEAKING THROUGH THE GRAFT. THE PRODUCT REMAINED IMPLANTED. NO INFORMATION ABOUT THE CONSEQUENCE FOR PATIENT COULD BE OBTAINED AT THE DATE OF THIS REPORT.
Patient problems: Blood Loss
MAUDE report 6583792 ↗MalfunctionJun 13, 2016Manufacturing, Packaging or Shipping Problem; Manufacturing, Packaging or Shipping Problem
DURING AN EXTRAANATOMICAL BYPASS SURGERY PERFORMED ON (B)(6) 2016 FOR AN ABDOMINAL AORTIC ANEURYSMA, IT WAS REPORTED A BLEEDING THROUGH THE GRAFT. THE BLEEDING OCCURRED DURING SEWING THE ANASTOMOSIS AND STOPPED BY ITSELF AFTER WAITING NEARLY HALF AN HOUR. THE GRAFT REMAINED IMPLANTED. NO ADVERSE CONSEQUENCE FOR THE PATIENT HAS BEEN REPORTED.
Patient problems: Blood Loss
MAUDE report 5720234 ↗InjuryOct 2, 2015Improper or Incorrect Procedure or Method
DURING A CARDIAC SURGERY, THE GRAFT WAS USED TO CONNECT THE FEMORAL ARTERY TO THE CARDIOPULMONARY BYPASS MACHINE. THE GRAFT WAS REPORTED TO LEAK FROM THE BODY ITSELF, WHICH REQUIRED THE USE OF HEMOSTATIC AGENT TO STOP THE BLEEDING BEFORE PROCEEDING WITH THE OPERATION. PATIENT HAD NO COMPLICATION. THE PRODUCT WAS DISCARDED AFTER USE.
Patient problems: Blood Loss
MAUDE report 5123644 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K964625. One submission often covers many models, so check the product and lot details in each record.
- Z-1439-2010 · Dec 9, 2009 · TerminatedInterGard Knitted Collagen Coated Vascular prostheses marketed under 510(k) # K964625; InterGard Woven Collagen Coated Vascular prostheses marketed under 510(k} #K970843 and K9842
- Z-1427-2010 · Dec 9, 2009 · TerminatedInterGard Knitted Collagen Coated Vascular prostheses, Catalog number: IGK1206. InterVascular SAS, France. Indicated for surgical repair, bypass or replacement of arteries in th
Other Prosthesis, Vascular Graft, Of 6mm And Greater Diameter devices
- Cardioroot HEWROOT0030Intervascular Sas · Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 recall2 deaths13 reports
- FLIXENE SLIDER GDS 25058Atrium Medical Corporation · PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER1 recall13 reports
- ADVANTA SLIDER GDS 22114Atrium Medical Corporation · PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER1 recall11 reports
- Cardioroot HEWROOT0032Intervascular Sas · Prosthesis, Vascular Graft, Of 6mm And Greater Diameter1 recall2 deaths10 reports
- FLIXENE SLIDER GDS 25129Atrium Medical Corporation · PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER1 recall9 reports
- FLIXENE SLIDER GDS 25137Atrium Medical Corporation · PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER1 recall8 reports
- ADVANTA SLIDER GDS 22222Atrium Medical Corporation · PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER1 recall8 reports
- FLIXENE SLIDER GDS 25138Atrium Medical Corporation · PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER1 recall7 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page